Uncategorized
Jetrea approved in South Korea for symptomatic vitreomacular adhesion
Jetrea has been approved in South Korea for the treatment of symptomatic vitreomacular adhesion, according to a ThromboGenics press release.This is the fourth country in Asia, behind Malaysia, Singapore and Taiwan, to approve the intravitreal injection.